Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20223726 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
Condition: Chronic Lymphocytic Leukaemia
Intervention:

Study has passed its completion date and status has not been verified in more than two years.